User login
Many newly designed cancer-treatment trials are incorporating detailed genetic analyses in their prospective design. A consequence is that the trials need to screen and include large numbers of patients to allow for statistically meaningful data to result.
Watch our exclusive interview here:
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Many newly designed cancer-treatment trials are incorporating detailed genetic analyses in their prospective design. A consequence is that the trials need to screen and include large numbers of patients to allow for statistically meaningful data to result.
Watch our exclusive interview here:
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Many newly designed cancer-treatment trials are incorporating detailed genetic analyses in their prospective design. A consequence is that the trials need to screen and include large numbers of patients to allow for statistically meaningful data to result.
Watch our exclusive interview here: